InvestorsHub Logo
Followers 10
Posts 1040
Boards Moderated 0
Alias Born 07/08/2006

Re: Gman24 post# 296114

Sunday, 07/29/2018 5:29:45 PM

Sunday, July 29, 2018 5:29:45 PM

Post# of 402159
Good point. That 23 mil study would not have been conducted if the Michael J. Fox Foundation had not funded the preclinical work and PH II study. It was this research that made the connection between Parkinson's and the benefits of isradipine.

the point is someone or thing thought so much of the Study. That they were willing to spend $23 million on it.



"Scientists believe isradipine works to prevent the death of dopamine-producing cells and therefore may slow the progression of PD. The Michael J. Fox Foundation (MJFF) funded pre-clinical work to make that connection, as well as the Phase II trial. In 2014,"

https://www.michaeljfox.org/foundation/news-detail.php?record-pace-of-recruitment-speeds-isradipine-trial
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News